BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-08052667 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-08052667\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07206225-11281@assetmemo.bio
DTSTAMP:20261121T010122Z
DTSTART;VALUE=DATE:20300129
DTEND;VALUE=DATE:20300130
SUMMARY:PF-08052667: Phase 1 readout est. (NCT07206225)
DESCRIPTION:PF-08052667\, phase 1\, Non-Muscle Invasive Bladder Cancer.\nSt
 udy: A Study to Learn About the Study Medicine PF-08052667 in People With 
 Bladder Cancer\nEstimated primary completion: 29 January 2030. This is a C
 linicalTrials.gov estimate\, not a confirmed readout date\, and it can mov
 e.\nDrug page: https://assetmemo.bio/drug/pf-08052667#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07206225
URL:https://assetmemo.bio/drug/pf-08052667#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
